C-Jun NH2-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma

Clinical Cancer Research

Volumn 9, Issue 1 I, 2003, Pages 391-401

  Yang, Yong Min ^a,e   Bost, Frédéric ^a,f   Charbono, Wilfried ^a   Dean, Nicholas ^b   McKay, Robert ^b   Rhim, Johng S ^c   Depatie, Chantal ^a   Mercola, Dan ^a,d  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

^b ISIS PHARMACEUTICALS   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e IgE Therapeutics Inc   (United States)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ANTISENSE STRESS ACTIVATED PROTEIN KINASE 1; ANTISENSE STRESS ACTIVATED PROTEIN KINASE 2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN FUNCTION; PROTEIN TARGETING; STRESS; TUMOR REGRESSION; XENOGRAFT;

ANIMALS; APOPTOSIS; CARCINOMA; CELL DIVISION; CELL LINE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDES, ANTISENSE; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037237136     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Davis, R. J. Signal transduction by the JNK group of MAP kinases. Cell, 103: 239-252, 2000.
2. Shaulian, E., and Karin, M. AP-1 in cell proliferation and survival. Oncogene, 20: 2390-400, 2001.
3. Gupta, S., Campbell, D., Derijard, B., and Davis, R. J. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science (Wash. DC), 267: 389-393, 1995.
4. Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanagh, J., Sluss, H. K., Derijard, B., and Davis, R. J. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J., 15: 2760-2770, 1996.
5. Xia, Y., Makris, C., Su, B., Li, E., Yang, J., Nemerow, G. R., and Karin, M. MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc. Natl. Acad. Sci. USA, 97: 5243-5248, 2000.
6. Cheng, J., Yang, J., Xia, Y., Karin, M., and Su, B. Synergistic interaction of MEK kinase 2, c-Jun N-terminal kinase (JNK) kinase 2, and JNK1 results in efficient and specific JNK1 activation. Mol. Cell. Biol., 20: 2334-2342, 2000.
7. Whitmarsh, A. J., Cavanagh, J., Tournier, C., Yasuda, J., and Davis, R. J. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science (Wash. DC), 281: 1671-1674, 1998.
8. Marti, A., Luo, Z., Cunningham, C., Ohta, Y., Hartwig, J., Stossel, T. P., Kyriakis, J. M., and Avruch, J. Actin-binding protein-280 binds the stress-activated protein kinase (SAPK) activator SEK-1 and is required for tumor necrosis factor-α activation of SAPK in melanoma cells. Biol Chem., 272: 2620-2680, 1997.
9. Faris, M., Kokot, N., Latinis, K., Kasibhatla, S., Green, D. R., Koretzky, G. A., and Nel, A. The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. J. Immunol., 160: 134-144, 1998.
10. Kasibhatla, S., Tailor, P., Bonefoy-Berard, N., Mustelin, T., Altman, A., and Fotedar, A. Jun kinase phosphorylates and regulates the DNA binding activity of an octamer binding protein. T-cell factor β1, Mol. Cell. Biol., 19: 2021-2031, 1999.
11. Whitmarsh, A. J., and Davis, R. J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med., 74: 589-607, 1996.
12. Ip, Y. T., and Davis, R. J. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr. Opin. Cell Biol., 10: 205-219, 1998.
13. Chow, C. W., Rincon, M., Cavanagh, J., Dickens, M., and Davis, R. J. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science (Wash. DC), 278: 1638-1641, 1997.
14. Chow, C. W., Dong, C., Flavell, R. A., and Davis, R. J. c-Jun NH(2)-terminal kinase inhibits targeting of the protein phosphatase calcineurin to NFATc1. Mol. Cell. Biol., 20: 5227-5234, 2000.
15. Pulverer, B. J., Kyriakis, J. M., Avruch, J., Nikolakaki, E., and Woodgett, J. R. Phosphorylation of c-jun mediated by MAP kinases. Nature (Lond.), 353: 670-674, 1991.
16. Smeal, T., Binetruy, B., Mercola, D. A., Birrer, M., and Karin, M. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature (Lond.), 354: 494-496, 1991.
17. Karin, M., Liu, Z., and Zandi, E. AP-1 function and regulation. Curr. Opin. Cell Biol., 9: 240-246, 1997.
18. Rinehart-Kim, J., Johnston, M., Birrer, M., and Bos, T. Alterations in the gene expression profile of MCF-7 breast tumor cells in response to c-Jun. Int. J. Cancer, 88: 180-190, 2000.
19. Fu, S. L., Waha, A., and Vogt, P. K. Identification and characterization of genes upregulated in cells transformed by v-Jun. Oncogene, 19: 3537-3545, 2000.
20. Vogt, P. K. Jun, the oncoprotein. Oncogene, 20: 2365-2377, 2001.
21. Reed, J. C., and Kroemer, G. Mechanisms of mitochondrial membrane permeabilization. Cell Death Differ., 7: 1145, 2000.
22. Yang, D. D., Kuan, C. Y., Whitmarsh, A. J., Rincon, M., Zheng, T. S., Davis, R. J., Rakic, P., and Flavell, R. A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature (Lond.), 389: 865-870, 1997.
23. Behrens, A., Sibilia, M., and Wagner, E. F. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat. Genet., 21: 326-329, 1999.
24. Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., and Davis, R. J. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science (Wash. DC), 288: 870-874, 2000.
25. Fuchs, S. Y., Adler, V., Pincus, M. R., and Ronai, Z. MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. USA, 95: 10541-10546, 1998.
26. Behrens, A., Jochum, W., Sibilia, M., and Wagner, E. F. Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene, 19: 2657-2663, 2000.
27. Clark, G. J., Westwick, J. K., and Der, C. J. p120 GAP modulates Ras activation of Jun kinases and transformation. J. Biol. Chem., 272: 1677-1681, 1997.
28. Minden, A., Lin, A., Claret, F. X., Abo, A., and Karin, M. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell, 81: 1147-1157, 1995.
29. Franklin, C. C., Sanchez, V., Wagner, F., Woodgett, J. R., and Kraft, A. S. Phorbol ester-induced amino-terminal phosphorylation of human JUN but not JUNB regulates transcriptional activation. Proc. Natl. Acad. Sci. USA, 89: 7247-7251, 1992b.
30. Smeal, T., Binetruy, B., Mercola, D., Grover-Bardwick, A., Heidecker, G., Rapp, U. R., and Karin, M. Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol. Cell. Biol., 12: 3507-3513, 1992.
31. Tolkacheva, T., Feuer, B., Lorenzi, M. V., Saez, R., and Chan, A. M. Cooperative transformation of NIH3T3 cells by G α12 and Rac1. Oncogene, 15: 727-735, 1997.
32. Wu, W. J., Lin, R., Cerione, R. A., and Manor, D. Transformation activity of Cdc42 requires a region unique to Rho-related proteins. J. Biol. Chem., 273: 16655-16658, 1998c.
33. Glaven, J. A., Whitehead, I., Bagrodia, S., Kay, R., and Cerione, R. A. The Db1-related protein. Lfc, localizes to microtubules and mediates the activation of Rac signaling pathways in cells. J. Biol. Chem., 274: 2279-2285, 1999.
34. Moriguchi, T., Toyoshima, F., Masuyama, N., Hanafusa, H., Gotoh, Y., and Nishida, E. A novel SAPK/JNK kinase. MKK7, stimulated by TNFα and cellular stresses. EMBO J., 16: 7045-7053, 1997.
35. Tanaka, S., and Hanafusa, H. Guanine-nucleotide exchange protein C3G activates JNK1 by a ras-independent mechanism. JNK1 activation inhibited by kinase negative forms of MLK3 and DLK mixed lineage kinases. J. Biol. Chem., 273: 1281-1284, 1998.
36. Crespo, P., Schuebel, K. E., Ostrom, A. A., Gutkind, J. S., and Bustelo, X. R. Phosphotyrosine-dependent activation of Rac-1 GDP/ GTP exchange by the vav proto-oncogene product. Nature (Lond.), 385: 169-172, 1997.
37. del Peso, L., Hernandez-Alcoceba, R., Embade, N., Carnero, A., Esteve, P., Paje, C., and Lacal, J. C. Rho proteins induce metastatic properties in vivo. Oncogene, 15: 3047-3057, 1997.
38. Lamorte, L., Kamikura, D. M., and Park, M. A switch from p130Cas/Crk to Gab1/Crk signaling correlates with anchorage independent growth and JNK activation in cells transformed by the Met receptor oncoprotein. Oncogene, 19: 5973-5981, 2000.
39. Rodrigues, G. A., Park, M., and Schlessinger, J. Activation of the JNK pathway is essential for transformation by the Met oncogene. EMBO J., 16: 2634-2645, 1997.
40. Antonyak, M. A., Moscatello, D. K., and Wong, A. J. Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor. J. Biol. Chem., 273: 2817-2822, 1998.
41. Bost, F., McKay, R., Bost, M., Potapova, O., Dean, N. M., and Mercola, D. The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells. Mol. Cell. Biol., 19: 1938-1949, 1999.
42. Bost, F., Potapova, O., Liu, C., Zhang, Y-M., Charbono, W., Dean, N., McKay, and Mercola, D. High Frequence regression of established human prostate carcinoma PC3 xenografts by systemic treatment with with antisense antisense jun kinase. Prostate, 38: 320-321, 1999.
43. Bost, F., McKay, R., Dean, N., and Mercola, D. The JUN kinase/ stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. J. Biol. Chem., 272: 33422-33429, 1997.
44. Burgess, G. S., Williamson, E. A., Cripe, L. D., Litz-Jackson, S., Bhatt, J. A., Stanley, K., Stewart, M. J., Kraft, A. S., Nakshatri, H., and Boswell, H. S. Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase. Blood, 92: 2450-2460, 1998.
45. Clarke, N., Arenzana, N., Hai, T., Minden, A., and Prywes, R. Epidermal growth factor induction of the c-jun promoter by a Rac pathway. Mol. Cell. Biol., 18: 1065-1073, 1998.
46. Dickens, M., Rogers, J. S., Cavanagh, J., Raitano, A., Xia, Z., Halpern, J. R., Greenberg, M. E., Sawyers, C. L., and Davis, R. J. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science (Wash. DC), 277: 693-696, 1997.
47. Logan, S. K., Falasca, M., Hu, P., and Schlessinger, J. Phosphatidylinositol 3-kinase mediates epidermal growth factor-induced activation of the c-Jun N-terminal kinase signaling pathway. Mol. Cell. Biol., 17: 5784-5790, 1997.
48. Parda, D. S., Thraves, P. J., Kuettel, M. R., Lee, M. S., Arnstein, P., Kaighn, M. E., Rhim, J. S., and Dritschilo, A. Neoplastic transformation of a human prostate epithelial cell line by the v-Ki-ras oncogene. Prostate, 23: 91-98, 1993.
49. Potapova, O., Haghighi, A., Bost, F., Liu, C., Birrer, M. J., Gjerset, R., and Mercola, D. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem., 272: 14041-14044, 1997.
50. Smith, L. M., Wise, S. C., Hendricks, D. T., Sabichi. A. L., Bos, T., Reddy, P., Brown, P. H., and Birrer, M. J. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene, 18: 6063-6070, 1999.
51. Cripe, L. D., Gelfanov, V. M., Smith, E. A., Spigel, D. R., Phillips, C. A., Gabig, T. G., Jung, S-H., Fyffe, J., Hartman, A. D., Kneebone, P., Mercola, D., Burgess, G. S., Boswell, H. S. Role for c-Jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-effux and hyperproliferation. Blood, 5: 799-812, 2002.
52. Potapova, O., Gorospe, M., Bost, F., Dean, N. M., Gaarde, W. A., Mercola, D., and Holbrook, N. J. c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells. J. Biol. Chem., 275: 24767-75, 2000a.
53. Sabapathy, K., Kallunki, T., David, J. P., Graef, I., Karin, M., and Wagner, E. F. c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage- dependent roles in regulating T cell apoptosis and proliferation. J. Exp. Med., 193: 317-328, 2001.
54. Kuan, C. Y., Yang, D. D., Samanta Roy, D. R., Davis, R. J., Rakic, P., and Flavell, R. A. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron, 22: 667-676, 1999.
55. Butterfield, L., Storey, B., Maas, L., and Heasley, L. E. c-Jun NH2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J. Biol. Chem., 272: 10110-10116, 1997.
56. Cioffi, C. L., and Monia, B. P. Evaluation of biological role of c-Jun N-terminal kinase using an antisense approach. Methods Enzymol., 314: 363-378, 2000.
57. Garay, M., Gaarde, W., Monia, B. P., Nero, P., and Cioffi, C. L. Inhibition of hypoxia/reoxygenation-induced apoptosis by an antisense oligonucleotide targeted to JNK1 in human kidney cells. Biochem. Pharmacol., 59: 1033-1043, 2000.
58. Hreniuk, D., Garay, M., Gaarde, W., Monia, B. P., McKay, R. A., and Cioffi, C. L. Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes. Mol. Pharmacol., 59: 867-874, 2001.
59. Soh, J. W., Mao, Y., Kim, M. G., Pamukcu, R., Li, H., Piazza, G. A., Thompson, W. J., and Weinstein, I. B. Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1. Clin. Cancer Res., 6: 4136-4141, 2000.
60. Arbour, N., Naniche, D., Homann, D., Davis, R. J., Flavell, R. A., and Oldstone, M. B. c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity. J. Exp. Med., 195: 801-810, 2002.
61. Cerezo, A., Martinez, A. C., Lanzarot, D., Fischer, S., Franke, T. F., and Rebollo, A. Role of Akt and c-Jun N-terminal kinase 2 in apoptosis induced by interleukin-4 deprivation. Mol. Biol. Cell., 9: 3107-3118, 1998.
62. Conze, D., Krahl, T., Kennedy, N., Weiss, L., Lumsden, J., Hess, P., Flavell, R. A., Le Gros, G., Davis, R. J., and Rincon, M. c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation. J. Exp. Med., 195: 811-823, 2002.
63. Chen, N., Nomura, M., She, Q. B., Ma, W. Y., Bode, A. M., Wang, L., Flavell, R. A., and Dong, Z. Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. Cancer Res., 61: 3908-3912, 2001a.
64. Muraki, J., Addonizio, J. C., Choudhury, M. S., Fischer, J., Eshghi, M., Davidian, M. M., Shapiro, L. R., Wilmot, P. L., Nagamatsu, G. R., and Chiao, J. W. Establishment of new human prostatic cancer cell line (JCA-1). Urology, 36: 79-84, 1990.
65. Iizumi, T., Yazaki, T., Kanoh, S., Kondo, I., and Koiso, K. Establishment of a new prostatic carcinoma cell line (TSU-Pr1). J. Urol., 137: 1304-1306, 1987.
66. van Bokhoven, A., Varella-Garcia, M., Korch, C., Hessels, D., and Miller, G. J. Widely used prostate carcinoma cell lines share common origins. Prostate, 47: 36-51, 2001b.
67. Potapova, O., Fakhrai, H., Baird, S., and Mercola, D. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells. Cancer Res., 56: 280-286, 1996a.
68. Potapova, O., Fakhrai, H., and Mercola, D. Growth factor PDGFB/v-sis confers a tumorigenic phenotype to human tumor cells bearing PDGF receptors but not to cells devoid of receptors: evidence for an autocrine, but not a paracrine, mechanism. Int. J. Cancer, 66: 669-677, 1996b.
69. Huang, R. P., Liu, C., Fan, Y., Mercola, D., and Adamson, E. D. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res., 55: 5054-5062, 1995.
70. Huang, R. P., Fan, Y., de Belle, I., Niemeyer, C., Gottardis, M. M., Mercola, D., and Adamson, E. D. Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int. J. Cancer, 72: 102-109, 1997.
71. Dean, N. M., and McKay, R. Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA, 91: 11762-6, 1994.
72. Klinman, D. M., Yi, A. K., Beaucage, S. L., Conover, J., and Krieg, A. M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc. Natl. Acad. Sci. USA, 93: 2879-2883, 1996.
73. Bost, F., McKay, R., Dean, N. M., Potapova, O., and Mercola, D. Antisense methods for discrimination of phenotypic properties of closely related gene products: Jun kinase family. Methods Enzymol., 314: 342-362, 2000.
74. Mercola, D. The proto-oncogene c-fos encodes a potential regulatory site that is disrupted by viral transduction. J. Theor. Biol., 126: 243-246, 1987.
75. Boven, E., Winograd, B., Berger, D. P., Dumont, M. P., Braakhuis, B. J., Fodstad, O., Langdon, S., and Fiebig, H. H. Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study. Cancer Res., 52: 5940-5947, 1992.
76. Costa-Pereira, A. P., McKenna, S. L., and Cotter, T. G. Activation of SAPK/JNK by camptothecin sensitizes androgen-independent prostate cancer cells to Fas-induced apoptosis. Br. J. Cancer, 82: 1827-1834, 2000.
77. Yazaki, T., Ahmad, S., Chahlavi, A., Zylber-Katz, E., Dean, N. M., Rabkin, S. D., Martuza, R. L., and Glazer, R. I. Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-α phosphorothioate oligodeoxynucleotide. Mol. Pharmacol., 50: 236-242, 1996.
78. Wernert, N. The multiple roles of tumour stroma. Virchows Arch., 430: 433-443, 1997.
79. Glinsky, G., V., Glinskii, A. B., McClelland, M., Krones-Herzig, A., Mercola, D., and Welsh, J. Microarray gene expression analysis of tumor progression in the nude mouse model of human prostate cancer, Proc. Am. Assoc. Cancer Res., 43: 4480, 2002.
80. Wyllie, A. H. The biology of cell death in turnouts. Anticancer Res., 5: 131-136, 1985.